Search

Search Constraints

You searched for: Author/Creator Nikkho, Sylvia

Search Results

5. Effect of riociguat on pulmonary arterial compliance in the PATENT and CHEST studies. (1st November 2020)

7. Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension. (1st November 2020)

8. Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension. (November 2020)

9. Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial. Issue 5 (May 2016)

10. Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial. Issue 5 (May 2016)